Investigation of the protective effects of phlorizin on diabetic cardiomyopathy in db/db mice by quantitative proteomics

Journal of Diabetes Research

Volumn 2013, Issue , 2013, Pages

  Cai, Qian ^a   Li, Baoying ^a   Yu, Fei ^a   Lu, Weida ^a   Zhang, Zhen ^a   Yin, Mei ^a   Gao, Haiqing ^a  

^a SHANDONG UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ADVANCED GLYCATION END PRODUCT; CHOLESTEROL; GLUCOSE; LIPID; PHLORIZIN; TRIACYLGLYCEROL;

ANALYSIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DIABETIC CARDIOMYOPATHY; DRUG EFFECT; GLUCOSE BLOOD LEVEL; HEART MUSCLE; INGENUITY PATHWAY ANALYSIS; LIPID METABOLISM; MALE; MITOCHONDRION; MORPHOLOGY; MOUSE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEOMICS; QUANTITATIVE ANALYSIS; QUANTITATIVE PROTEOMICS; WEIGHT GAIN;

EID: 84879369264     PISSN: 23146745     EISSN: 23146753     Source Type: Journal    
DOI: 10.1155/2013/263845     Document Type: Article

References (29)

1. Stamler J., Vaccaro O., Neaton J. D., Wentworth D., Diabetes, other risk factors, and 12-yr cardiovascular mortality for men screened in the multiple risk factor intervention trial. Diabetes Care 1993 16 2 434 444 2-s2.0-0027406191 (Pubitemid 23046633)
2. Sarwar N., Gao P., Seshasai S. R., Gobin R., Kaptoge S., Di Angelantonio E., Ingelsson E., Lawlor D. A., Selvin E., Stampfer M., Stehouwer C. D., Lewington S., Pennells L., Thompson A., Sattar N., White I. R., Ray K. K., Danesh J., Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studies. The Lancet 2010 375 9733 2215 2222
3. Rubler S., Dlugash J., Yuceoglu Y. Z., Kumral T., Branwood A. W., Grishman A., New type of cardiomyopathy associated with diabetic glomerulosclerosis. The American Journal of Cardiology 1972 30 6 595 602 2-s2.0-0015498586
4. Boyer J. K., Thanigaraj S., Schechtman K. B., Pérez J. E., Prevalence of ventricular diastolic dysfunction in asymptomatic, normotensive patients with diabetes mellitus. The American Journal of Cardiology 2004 93 7 870 875 2-s2.0-1842529750 10.1016/j.amjcard.2003.12.026 (Pubitemid 38429599)
5. Fein F. S., Sonnenblick E. H., Diabetic cardiomyopathy. Progress in Cardiovascular Diseases 1985 27 4 255 270 (Pubitemid 15158896)
6. Wojdyło A., Oszmiański J., Laskowski P., Polyphenolic compounds and antioxidant activity of new and old apple varieties. Journal of Agricultural and Food Chemistry 2008 56 15 6520 6530 2-s2.0-50449097730 10.1021/jf800510j
7. Ehrenkranz J. R., Lewis N. G., Kahn C. R., Roth J., Phlorizin: a review. Diabetes/Metabolism Research and Reviews 2005 21 1 31 38 2-s2.0-12744253796 10.1002/dmrr.532
8. Hummel K. P., Dickie M. M., Coleman D. L., Diabetes, a new mutation in the mouse. Science 1966 153 3740 1127 1128 2-s2.0-0014004384
9. Herberg L., Coleman D. L., Laboratory animals exhibiting obesity and diabetes syndromes. Metabolism 1977 26 1 59 99 2-s2.0-0017349397 (Pubitemid 8027641)
10. Hu J., Qian J., Borisov O., Pan S., Li Y., Liu T., Deng L., Wannemacher K., Kurnellas M., Patterson C., Elkabes S., Li H., Optimized proteomic analysis of a mouse model of cerebellar dysfunction using amine-specific isobaric tags. Proteomics 2006 6 15 4321 4334 2-s2.0-33747791792 10.1002/pmic.200600026 (Pubitemid 44277034)
11. Ross P. L., Huang Y. N., Marchese J. N., Williamson B., Parker K., Hattan S., Khainovski N., Pillai S., Dey S., Daniels S., Purkayastha S., Juhasz P., Martin S., Bartlet-Jones M., He F., Jacobson A., Pappin D. J., Multiplexed protein quantitation in Saccharomyces cerevisiae using amine-reactive isobaric tagging reagents. Molecular and Cellular Proteomics 2004 3 12 1154 1169 2-s2.0-19944432197 10.1074/mcp.M400129-MCP200
12. Zhao G., Gao H., Qiu J., Lu W., Wei X., The molecular mechanism of protective effects of grape seed proanthocyanidin extract on reperfusion arrhythmias in rats in vivo. Biological and Pharmaceutical Bulletin 2010 33 5 759 767 2-s2.0-77952354732 10.1248/bpb.33.759
13. Li X. L., Li B. Y., Gao H. Q., Cheng M., Xu L., Li X. H., Zhang W. D., Hu J. W., Proteomics approach to study the mechanism of action of grape seed proanthocyanidin extracts on arterial remodeling in diabetic rats. International Journal of Molecular Medicine 2010 25 2 237 248 2-s2.0-73649138248 10.3892/ijmm-00000336
14. van de Weijer T., Schrauwen-Hinderling V. B., Schrauwen P., Lipotoxicity in type 2 diabetic cardiomyopathy. Cardiovascular Research 2011 92 1 10 18 10.1093/cvr/cvr212
15. Battiprolu P. K., Gillette T. G., Wang Z. V., Lavandero S., Hill J. A., Diabetic cardiomyopathy: mechanisms and therapeutic targets. Drug Discovery Today 2010 7 2 e135 e143 2-s2.0-78649326868 10.1016/j.ddmec.2010.08.001
16. Duncan J. G., Mitochondrial dysfunction in diabetic cardiomyopathy. Biochimica et Biophysica Acta 2011 1813 7 1351 1359 2-s2.0-79957969004 10.1016/j.bbamcr.2011.01.014
17. An D., Rodrigues B., Role of changes in cardiac metabolism in development of diabetic cardiomyopathy. The American Journal of Physiology, Heart and Circulatory Physiology 2006 291 4 H1489 H1506 2-s2.0-33749321945 10.1152/ajpheart.00278.2006 (Pubitemid 44497651)
18. Rezk B. M., Haenen G. R, van der Vijgh W. J. F., Bast A., The antioxidant activity of phloretin: the disclosure of a new antioxidant pharmacophore in flavonoids. Biochemical and Biophysical Research Communications 2002 295 1 9 13 2-s2.0-0036306766 10.1016/S0006-291X(02)00618-6 (Pubitemid 34743766)
19. Cusi K., The role of adipose tissue and lipotoxicity in the pathogenesis of type 2 diabetes. Current Diabetes Reports 2010 10 4 306 315 2-s2.0-77956395533 10.1007/s11892-010-0122-6
20. Kankaanpää M., Lehto H. R., Pärkkä J. P., Komu M., Viljanen A., Ferrannini E., Knuuti J., Nuutila P., Parkkola R., Iozzo P., Myocardial triglyceride content and epicardial fat mass in human obesity: relationship to left ventricular function and serum free fatty acid levels. Journal of Clinical Endocrinology and Metabolism 2006 91 11 4689 4695 2-s2.0-33751546348 10.1210/jc.2006-0584 (Pubitemid 44833458)
21. Wende A. R., Abel E. D., Lipotoxicity in the heart. Biochimica et Biophysica Acta 2010 1801 3 311 319 2-s2.0-76349119251 10.1016/j.bbalip.2009.09. 023
22. Bartels E. D., Nielsen J. M., Hellgren L. I., Ploug T., Nielsen L. B., Cardiac expression of microsomal triglyceride transfer protein is increased in obesity and serves to attenuate cardiac triglyceride accumulation. PLoS ONE 2009 4 4 2-s2.0-65449137930 10.1371/journal.pone.0005300 e5300
23. Chang Y.-H., Chang D.-M., Lin K.-C., Shin S.-J., Lee Y.-J., Visfatin in overweight/obesity, type 2 diabetes mellitus, insulin resistance, metabolic syndrome and cardiovascular diseases: a meta-analysis and systemic review. Diabetes/Metabolism Research and Reviews 2011 27 6 515 527 10.1002/dmrr.1201
24. Coughlan M. T., Thorburn D. R., Penfold S. A., Laskowski A., Harcourt B. E., Sourris K. C., Tan A. L. Y., Fukami K., Thallas-Bonke V., Nawroth P. P., Brownlee M., Bierhaus A., Cooper M. E., Forbes J. M., Rage-induced cytosolic ROS promote mitochondrial superoxide generation in diabetes. Journal of the American Society of Nephrology 2009 20 4 742 752 2-s2.0-65249153029 10.1681/ASN.2008050514
25. Zhi Y. F., Prins J. B., Marwick T. H., Diabetic cardiomyopathy: evidence, mechanisms, and therapeutic implications. Endocrine Reviews 2004 25 4 543 567 2-s2.0-4143140134 10.1210/er.2003-0012 (Pubitemid 39096070)
26. Saito F., Kawaguchi M., Izumida J., Asakura T., Maehara K., Maruyama Y., Alteration in haemodynamics and pathological changes in the cardiovascular system during the development of type 2 diabetes mellitus in OLETF rats. Diabetologia 2003 46 8 1161 1169 2-s2.0-0041877454 10.1007/s00125-003-1156-y (Pubitemid 37041247)
27. Borbély A., van Heerebeek L., Paulus W. J., Editorial: transcriptional and posttranslational modifications of titin: implications for diastole. Circulation Research 2009 104 1 12 14 2-s2.0-59649115484 10.1161/CIRCRESAHA.108.191130
28. Ihara E., MacDonald J. A., The regulation of smooth muscle contractility by zipper-interacting protein kinase. Canadian Journal of Physiology and Pharmacology 2007 85 1 79 87 2-s2.0-34250792930 10.1139/Y06-103 (Pubitemid 46996106)
29. Kamm K. E., Stull J. T., Signaling to myosin regulatory light chain in sarcomeres. Journal of Biological Chemistry 2011 286 12 9941 9947 2-s2.0-79953183003 10.1074/jbc.R110.198697